CST3 and chronic kidney disease: In the meta-analysis by Roos et al. involving 24 studies, cut-off values of serum cystatin C, 0.9–1.4 mg/L was used to detect early renal impairment [39] and this range covers the chronic kidney disease patients in stages 1 and 2 in this study.